Serum alpha-fetoprotein (AFP) is recognized as a hepatocellular carcinoma (HCC)-specific marker [1], and older HCC guidelines included serum AFP measurement, combined with imaging studies, in the protocol for surveillance and diagnosis of HCC [2]. Here, AFP is linked to hepatocellular carcinoma.